BBH Holdings Information

BBH is an equity ETF with a total of 25 individual holdings. The top holdings are Amgen stock at 15.15%, Gilead Sciences at 12.77%, Vertex Pharmaceuticals at 9.30%, Regeneron Pharmaceuticals at 6.26%, and Revolution Medicines at 5.12%.

Total Holdings

Top 10 Percentage

70.26%

Asset Class

Equity

ETF Category

Health

Assets

365.74M

PE Ratio

22.39

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	15.15%	166,568
2	GILD	Gilead Sciences, Inc.	12.77%	400,338
3	VRTX	Vertex Pharmaceuticals Incorporated	9.30%	72,485
4	REGN	Regeneron Pharmaceuticals, Inc.	6.26%	39,388
5	RVMD	Revolution Medicines, Inc.	5.12%	111,381
6	NTRA	Natera, Inc.	4.87%	71,677
7	ARGX	argenx SE	4.84%	21,198
8	IQV	IQVIA Holdings Inc.	4.44%	88,160
9	ALNY	Alnylam Pharmaceuticals, Inc.	3.83%	50,358
10	MRNA	Moderna, Inc.	3.68%	189,951
11	BIIB	Biogen Inc.	3.49%	66,394
12	ILMN	Illumina, Inc.	3.27%	71,334
13	ONC	BeOne Medicines AG	2.82%	38,996
14	UTHR	United Therapeutics Corporation	2.79%	20,628
15	INSM	Insmed Incorporated	2.69%	99,048
16	INCY	Incyte Corporation	2.47%	86,946
17	NBIX	Neurocrine Biosciences, Inc.	2.07%	48,865
18	BNTX	BioNTech SE	1.96%	82,542
19	ICLR	ICON Public Limited Company	1.82%	43,319
20	TECH	Bio-Techne Corporation	1.49%	86,310
21	CRL	Charles River Laboratories International, Inc.	1.47%	26,203
22	BMRN	BioMarin Pharmaceutical Inc.	1.33%	92,530
23	QGEN	Qiagen N.V.	1.05%	107,713
24	TEM	Tempus AI, Inc.	0.98%	67,091
25	n/a	Us Dollar	0.05%	209,499

As of Jul 3, 2026